Clinical Trials Logo

Filter by:
NCT ID: NCT06094452 Completed - Alzheimer Disease Clinical Trials

Effects of 24-week Computerized Cognitive Training in Patients With MCI and AD

Start date: October 21, 2020
Phase: N/A
Study type: Interventional

This study aims to testify multi-domain effects of computerized cognitive training in patients with mild cognitive impairment and mild Alzheimer's disease through multi-dimensional evaluation.

NCT ID: NCT06094426 Recruiting - Solid Tumor Clinical Trials

Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors

Start date: February 26, 2023
Phase: Early Phase 1
Study type: Interventional

This trial is a multicenter, single-arm, open design designed to evaluate the safety and tolerability of Autologous Tumor Infiltrating Lymphocyte Injection in the treatment of patients with advanced solid tumors, as well as pharmacokinetic profiling and efficacy. The trial consists of two phases: dose-escalation and dose-expansion.

NCT ID: NCT06094179 Recruiting - Dermatitis, Atopic Clinical Trials

Evaluate the Safety, Tolerability of BAT6026

Start date: November 9, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Phase IB/IIA clinical study of BAT6026 in patients with AD. The subjects were adults with moderate to severe atopic dermatitis (AD) whose disease was not adequately controlled by prior topical medications or for which topical medications were not appropriate. The first phase was the phase IB study, which was double-blind controlled by placebo in the group and consisted of 3 dose groups. After completing the dose escalation study, the phase IIA study was entered. The Phase IIA study was a randomized, double-blind, controlled, multicentering clinical trial with different dose groups and placebo groups. The primary endpoint was to explore the efficacy and safety of BAT6026 in patients with eczema area and severity index (EASI) of at least 75% lower than the baseline at week 16 after 4 treatment cycles. To provide the optimal dose for the phase III regimen.

NCT ID: NCT06093997 Recruiting - Clinical trials for Cervical Spondylosis

Study on the Treatment of C/S of Qi Stagnation and Blood-stasis Type by Moving Cupping With Bloodletting

Start date: February 28, 2024
Phase: N/A
Study type: Interventional

The goal of this Clinical randomized controlled trial is to evaluate the therapeutic effect of cupping combined with bloodletting in the treatment of cervical spondylosis of qi stagnation and blood stasis type. The main question it aims to answer is: How to remove stasis and prolong the time of promoting blood circulation. Participants will adopt the combination of cupping and bloodletting therapy.Researchers will compare massage treatment to see if the combination of cupping and bloodletting puncture is more effective in treating cervical spondylosis of qi stagnation and blood stasis type

NCT ID: NCT06093945 Completed - Malignant Tumor Clinical Trials

Effect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects

Start date: November 6, 2023
Phase: Phase 1
Study type: Interventional

The study aimed to assess the effects of omeprazole on single-dose SHR2554 in healthy subjects, exploring the pharmacokinetic changes of SHR2554 and ensuring the safety when SHR2554 is co-administered with omeprazole.

NCT ID: NCT06093932 Recruiting - Clinical trials for Hypertension,Essential

Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial

ESCIHP
Start date: June 2024
Phase: Phase 4
Study type: Interventional

The purpose of this study is: 1. To evaluate the efficacy of Songling Xuemaikang Capsules(SLXMKC) with grade 1 hypertension. 2. To reveal the potiential effects of SLXMKC on vascular function and structure of patients with grade 1 hypertension. 3. To explore the underlying mechanisms of the therapeutic effects of SLXMKC on the intervention of grade 1 hypertension.

NCT ID: NCT06093854 Not yet recruiting - Spinal Metastases Clinical Trials

Intraoperative Radiotherapy in Treating Spinal Metastases

Start date: January 2024
Phase: N/A
Study type: Interventional

In order to provide theoretical evidence for the comprehensive and standardized treatment of spinal metastases with pathological fractures and/or spinal cord compression, the investigators conduct this trial to investigate the efficacy and safety of IORT and postoperative SBRT in adjuvant treatment of metastatic spinal tumors after posterior decompression surgery by recruiting patients with spinal metastases who met the inclusion criteria, and randomly divided them into the following treatment cohorts: 1) decompression surgery + IORT (15-20 Gy, 20-50min); 2) decompression surgery and postoperative SBRT(30Gy, 5 fractions, 3 weeks).

NCT ID: NCT06093841 Not yet recruiting - Clinical trials for Lymphoma, Large B-Cell, Diffuse

Relmacabtagene Autoleucel as Second-Line Therapy in Adult Patients With Aggressive B-cell NHL

Start date: November 2023
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to asess the efficacy of Relmacabtagene autoleucel as second-line therapy in adult patients with aggressive B-cell Non-Hodgkins Lymphoma who are ineligible for haematopoietic stem cell transplantation.

NCT ID: NCT06093438 Recruiting - Cervical Cancer Clinical Trials

Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer

Start date: July 1, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

To explore the efficacy of incorporating neoadjuvant immunotherapy into neoadjuvant chemotherapy in locally advanced cervical cancer patients with high risk of recurrence.

NCT ID: NCT06093412 Completed - Spinal Anesthesia Clinical Trials

Application of Unilateral Epidural Anesthesia in Older Patients With Hip Fracture

Start date: January 1, 2018
Phase:
Study type: Observational [Patient Registry]

Because of population ageing, fragility fractures have become a huge burden on healthcare systems and wider society. Fractures result in a sharp drop in both short-term and long-term quality of life, they have a strong influence on activities of daily living and mobility, and they are associated with a significant increase in 1-year mortality (18%-36%). Surgery can benefit elderly patients with hip fractures to an extent, but it entails inevitable risks, particularly with respect to general anesthesia. In recent years unilateral spinal anesthesia has attracted attention due to the advantages of hemodynamic stability, reduced anesthetic dosage, and sufficient sensory block. On the basis of a previous study, in the current study anesthetics were directly implanted into the unilateral epidural space in elderly patients with hip fractures prior to the completion of surgery. Data from 106 patients with old hip fractures who had undergone surgical treatment incorporating unilateral epidural anesthesia (UEA) or combined lumbar and epidural anesthesia were retrospectively analyzed in an attempt to provide a feasible solution for this kind of patients' anesthesia.